{"id":7496,"date":"2021-12-16T08:02:29","date_gmt":"2021-12-16T13:02:29","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/hot-sale-albiglutide-cas-782500-75-8-diabeteksen-hoitoon\/"},"modified":"2021-12-16T08:02:29","modified_gmt":"2021-12-16T13:02:29","slug":"hot-sale-albiglutide-cas-782500-75-8-diabeteksen-hoitoon","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fi\/product\/hot-sale-albiglutide-cas-782500-75-8-diabeteksen-hoitoon\/","title":{"rendered":"Hot Sale Albiglutide CAS 782500-75-8 diabeteksen hoitoon"},"content":{"rendered":"<h2><strong>Hot Sale Albiglutide CAS 782500-75-8 diabeteksen hoitoon<\/strong><\/h2>\n<p>Tuotteen nimi: Albiglutide<br \/>\nSekvenssi: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala- Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-OH<br \/>\nSynonyymit: albiglutidi; albugon; naliglutidi; 7-36-glukagonin kaltainen peptidi I (8-glysiini) (ihminen), fuusioproteiini 7-36-glukagonin kaltaisen peptidin I (8-glysiini) kanssa (ihmisen) fuusioproteiini seerumin kanssa; Gsk 716155; Unii-5E7U48495e; 7-36-Glukagonin kaltainen peptidi I [8-glysiini] ( huMan), fuusioproteiini 7-36-glukagonin kaltaisen peptidin I[8-glysiini] (huMan) kanssa fuusioproteiini seerumin kanssa albuMin (huMan); Albiglutidifragmentti<br \/>\nCAS: 782500-75-8<br \/>\nMF: C148H223N39O46<br \/>\nMW: 3284.58792<br \/>\nEINECS:<br \/>\nTuoteluokat: GLP<br \/>\nMol Tiedosto: 782500-75-8.mol<\/p>\n<p>Albiglutidi on FDA:n hyv\u00e4ksym\u00e4 tyypin 2 diabetes mellitukseen (DM) ja tyypin 2 diabeteksen aiheuttaman syd\u00e4n- ja verisuonij\u00e4rjestelm\u00e4n h\u00e4iri\u00f6iden ennaltaehk\u00e4isy. Sen annostukseen kuuluu titraus maha-suolikanavan oireiden, kuten pahoinvoinnin, ripulin ja oksentelun, v\u00e4hent\u00e4miseksi: aloita 0,6 mg:n p\u00e4ivitt\u00e4inen ihonalainen injektio 1 viikon ajan; nostetaan yll\u00e4pitoannokseen 1,2 mg p\u00e4iv\u00e4ss\u00e4; ja nosta 1,8 mg:aan p\u00e4ivitt\u00e4in tarpeen mukaan.<br \/>\nLiraglutidi on my\u00f6s FDA:n hyv\u00e4ksym\u00e4 Saxenda liikalihavuuden hoitoon, jonka painoindeksi on 30 kg\/m2 <or 27kg\/m2 with the presence of at least 1 weight-related comorbid condition. Saxenda is initiated at 0.6 mg subcutaneous daily injection for 1 week, with weekly increments of 0.6 mg per day, until the maintenance dosage of 3 mg once daily is reached.3 If the patient misses a dose of liraglutide injection for more than 3 days, re-initiation at 0.6 mg is recommended to mitigate gastrointestinal (GI) symptoms. <strong>Albiglutide CAS 782500-75-8:n toiminta ja k\u00e4ytt\u00f6 <\/strong><br \/>\nYhdysvaltain elintarvike- ja l\u00e4\u00e4kevirasto (FDA) hyv\u00e4ksyi 15. huhtikuuta 2014 virallisesti diabetesl\u00e4\u00e4kkeen Albiglutidin markkinointiin. L\u00e4\u00e4ke on toinen pitk\u00e4vaikutteinen GLP-1-analogi, joka on hyv\u00e4ksytty agonisoimaan GLP-1-reseptoria ja edist\u00e4m\u00e4\u00e4n insuliinin erityst\u00e4 tyypin 2 diabeteksen hoitoon.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tuotteen nimi: Albiglutidi<br \/>\nCAS: 782500-75-8<br \/>\nMF: C148H223N39O46<br \/>\nMW: 3284.58792<br \/>\nMol Tiedosto: 782500-75-8.mol<\/p>\n","protected":false},"featured_media":2205,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[340],"product_tag":[2256],"class_list":{"0":"post-7496","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-diabetes-peptidi","7":"product_tag-hot-sale-albiglutide-cas-782500-75-8-treat-for-diabetes-fi","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product\/7496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/comments?post=7496"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media\/2205"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media?parent=7496"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_brand?post=7496"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_cat?post=7496"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_tag?post=7496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}